ArticleAnnals of medicine2024

Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.

Maria Basagaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.